RPCAR01
/ Roswell Park Comprehensive Cancer Center
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
November 19, 2025
Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular Carcinoma
(clinicaltrials.gov)
- P1 | N=24 | Suspended | Sponsor: Roswell Park Cancer Institute | Recruiting ➔ Suspended
Trial suspension • Hepatocellular Cancer • Oncology • Solid Tumor
August 20, 2025
Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular Carcinoma
(clinicaltrials.gov)
- P1 | N=24 | Recruiting | Sponsor: Roswell Park Cancer Institute | Not yet recruiting ➔ Recruiting
Enrollment open • Hepatocellular Cancer • Oncology • Solid Tumor
May 13, 2025
Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular Carcinoma
(clinicaltrials.gov)
- P1 | N=24 | Not yet recruiting | Sponsor: Roswell Park Cancer Institute
New P1 trial • Hepatocellular Cancer • Oncology • Solid Tumor
1 to 3
Of
3
Go to page
1